Published in J Cardiovasc Pharmacol Ther on December 07, 2009
Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.95
Effects of restricted fructose access on body weight and blood pressure circadian rhythms. Exp Diabetes Res (2012) 0.77
Cardiovascular neural regulation explored in the frequency domain. Circulation (1991) 7.49
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr (2007) 5.28
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem (2002) 3.81
Fructose-induced insulin resistance and hypertension in rats. Hypertension (1987) 2.43
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol (2006) 2.41
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens (1987) 2.21
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension (2003) 2.10
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation (2005) 1.92
Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol (2008) 1.89
Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol (2004) 1.73
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int (2005) 1.71
Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68
ACE and ACE2 activity in diabetic mice. Diabetes (2006) 1.66
Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2005) 1.62
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens (2002) 1.51
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension (2004) 1.48
The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care (2006) 1.44
Sugary drinks in the pathogenesis of obesity and cardiovascular diseases. Int J Obes (Lond) (2008) 1.43
Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes (2006) 1.37
ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes (2008) 1.36
Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol (2009) 1.32
Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis (2004) 1.30
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides (1994) 1.26
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol (2004) 1.24
Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol (2009) 1.23
Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci (2006) 1.16
Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension (2003) 1.15
Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci (2006) 1.13
The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am J Hypertens (2004) 1.09
Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res (2001) 1.04
The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res (2006) 0.98
Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet. Am J Physiol Heart Circ Physiol (2007) 0.96
Novel angiotensin peptides. Cell Mol Life Sci (2004) 0.95
Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2006) 0.92
Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity. Hypertension (2005) 0.90
Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci (2008) 0.90
Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats. Eur J Pharmacol (1996) 0.88
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens (1996) 0.87
Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Am J Hypertens (1996) 0.85
Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice. Exp Physiol (2008) 0.84
Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats. Endocr J (2004) 0.84
Power spectral analysis in mice: What are the appropriate frequency bands? Am J Physiol Regul Integr Comp Physiol (2006) 0.82
Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus. Life Sci (2006) 0.82
Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats. Metabolism (2005) 0.82
Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats. Can J Physiol Pharmacol (1994) 0.81
Diabetic autonomic neuropathy. Cardiac sympathetic "dysinnervation," QT interval prolongation, and mortality. Clin Auton Res (2002) 0.79
Renal ACE and ACE2 expression in early diabetic rats. Nephron Exp Nephrol (2008) 0.79
Angiotensin receptors and development: the kidney. Clin Exp Pharmacol Physiol Suppl (1996) 0.79
Effects of fructose and/or fat in the diet on developing the type 2 diabetic-like syndrome in CD-1 mice. Horm Metab Res (2008) 0.77
AT1 receptor density changes during development of hypertension in hyperinsulinemic rats. Clin Exp Hypertens (1996) 0.77
Effects of losartan and benazepril on abnormal circadian blood pressure rhythm and target organ damage in SHRSP. Clin Exp Hypertens (2002) 0.76
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68
Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats. Am J Hypertens (2013) 2.11
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension (2004) 1.96
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation (2005) 1.92
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation (2002) 1.85
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol (2007) 1.85
AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res (2003) 1.84
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int (2005) 1.71
Adenovirus-mediated small-interference RNA for in vivo silencing of angiotensin AT1a receptors in mouse brain. Hypertension (2005) 1.60
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension (2009) 1.52
Angiogenic growth factors and hypertension. Angiogenesis (2004) 1.50
Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology (2009) 1.42
Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol (2008) 1.41
Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat. Hypertension (2003) 1.32
Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine (2002) 1.30
Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol (2009) 1.23
Baroreflex control of heart rate by oxytocin in the solitary-vagal complex. Am J Physiol Regul Integr Comp Physiol (2002) 1.22
Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring. Am J Physiol Regul Integr Comp Physiol (2007) 1.20
Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci (2006) 1.16
Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol (2007) 1.13
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension (2008) 1.10
Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. Am J Physiol Cell Physiol (2013) 1.10
The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology (2009) 1.08
Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985) (2012) 1.07
Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension (2011) 1.06
Hypertension caused by transgenic overexpression of Rac1. Antioxid Redox Signal (2007) 1.05
Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. Am J Physiol Renal Physiol (2010) 1.05
Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int (2002) 1.05
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am J Physiol Heart Circ Physiol (2006) 1.05
Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol (2009) 1.05
Cytochrome P4501A1 is required for vascular dysfunction and hypertension induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci (2010) 1.04
Neurobehavioral deficits in db/db diabetic mice. Physiol Behav (2010) 1.04
Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney. Am J Physiol Endocrinol Metab (2012) 1.04
Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. PLoS One (2013) 1.03
Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol (2009) 1.01
Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes. Am J Physiol Renal Physiol (2012) 1.01
Acute and chronic stress influence blood pressure variability in mice. Physiol Behav (2004) 1.00
The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). Am Heart J (2005) 0.99
New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension (2006) 0.99
Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles. J Transl Med (2012) 0.98
Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet. Am J Physiol Heart Circ Physiol (2007) 0.96
Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction. Hypertension (2011) 0.96
Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. Am J Physiol Heart Circ Physiol (2003) 0.95
Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance in mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.95
An activated renin-angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice. Biochem Pharmacol (2010) 0.95
Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice. PLoS One (2012) 0.95
The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study. Exp Mol Pathol (2007) 0.95
Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet (2006) 0.95
Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol Regul Integr Comp Physiol (2003) 0.94
Adenoviral inhibition of AT1a receptors in the paraventricular nucleus inhibits acute increases in mean arterial blood pressure in the rat. Am J Physiol Regul Integr Comp Physiol (2010) 0.94
Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension (2010) 0.94
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. Blood (2013) 0.94
Increased blood pressure in the offspring of diabetic mothers. Am J Physiol Regul Integr Comp Physiol (2005) 0.93
Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J Biol Chem (2007) 0.93
A brief review of chronic exercise intervention to prevent autonomic nervous system changes during the aging process. Clinics (Sao Paulo) (2009) 0.92
Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation. Clinics (Sao Paulo) (2010) 0.92
Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2006) 0.92
Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain. PLoS One (2012) 0.91
Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics (Sao Paulo) (2007) 0.91
Novel mass spectrometric methods for evaluation of plasma angiotensin converting enzyme 1 and renin activity. Hypertension (2005) 0.90
Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension? Hypertension (2005) 0.90
Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci (2008) 0.90
Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides. Hypertension (2004) 0.90
Stress cardiovascular/autonomic interactions in mice. Physiol Behav (2006) 0.90
Circadian differences in stress-induced pressor reactivity in mice. Hypertension (2002) 0.89
Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol. Am J Nephrol (2010) 0.89
Multiple testing strategy for the detection of temporal irreversibility in stationary time series. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.88
Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice. J Cardiovasc Pharmacol Ther (2012) 0.88
Cardiovascular autonomic control in mice lacking angiotensin AT1a receptors. Am J Physiol Regul Integr Comp Physiol (2004) 0.88
Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine (2007) 0.88
Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies. Ther Adv Cardiovasc Dis (2008) 0.87
Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats. J Card Fail (2011) 0.87
The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics. Am J Cardiovasc Drugs (2006) 0.87
Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology (2003) 0.87
Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice. J Psychopharmacol (2012) 0.87
Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol (Oxf) (2004) 0.86
Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis. Physiol Behav (2013) 0.86
Osmotic regulation of angiotensin AT1 receptor subtypes in mouse brain. Brain Res (2003) 0.86
Enhanced removal from the plasma of LDL-like nanoemulsion cholesteryl ester in trained men compared with sedentary healthy men. J Appl Physiol (1985) (2007) 0.86
Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension. Hypertension (2012) 0.86
Exercise training prevents diastolic dysfunction induced by metabolic syndrome in rats. Clinics (Sao Paulo) (2012) 0.86
Urinary oxytocin as a non-invasive biomarker for neurohypophyseal hormone secretion. Peptides (2006) 0.85
Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness. Biochem Pharmacol (2011) 0.85
Dietary sodium regulates angiotensin AT1a and AT1b mRNA expression in mouse brain. Exp Neurol (2004) 0.85
Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers. Acta Pharmacol Sin (2005) 0.85
RNA interference shows interactions between mouse brainstem angiotensin AT1 receptors and angiotensin-converting enzyme 2. Exp Physiol (2008) 0.85
Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. Am J Physiol Renal Physiol (2014) 0.85
Preventive role of exercise training in autonomic, hemodynamic, and metabolic parameters in rats under high risk of metabolic syndrome development. J Appl Physiol (1985) (2013) 0.85
Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries. Peptides (2003) 0.84